Ibogaine: A Potential Breakthrough for Addiction and Trauma?

Bookmark Article



Bookmark Article


On ‘What’s Trending,’ hosts Jessica Reyes, Patricia Wu, and guest MHTN Chief Medical Officer Dr. Dan Bober discuss how Ibogaine is showing promise for addiction, PTSD, and traumatic brain injuries in a recent study.

Ibogaine’s Impact on the Brain

Dr. Bober explains how ibogaine interacts with multiple neurotransmitter systems, including glutamate. Its effects on glutamate are similar to ketamine, which is being researched for mental health conditions.

Ibogaine is currently illegal in the US, but desperate patients may seek it through research or compassionate use protocols. Safety concerns, including potential side effects, are a major hurdle for broader use.

The Future of Psychedelic Medicine

Dr. Bober believes ibogaine could inspire pharmaceutical companies to develop similar but patentable drugs. This highlights the growing interest in psychedelics for mental health treatment.

Editorial Team
Editorial Team
At the heart of MHTN - America's pioneering 24/7 Mental Health TV Network - is our editorial team, a dynamic group of professionals united by a shared commitment to transforming the conversation around mental health. Our team is composed of seasoned journalists, mental health experts, researchers, and storytellers, each bringing a wealth of experience and a passion for advocacy.


Please enter your comment!
Please enter your name here

Read more


Related Articles